Eli Lilly makes bet on gene-silencing drug firm Dicerna

* Lilly to pay Dicerna $100 mln upfront plus $100 mln for stake

* Equity stake price of $18.47/shr is 42 pct premium to last close

* Dicerna closed at $13 on Friday